Contrast Media & Molecular Imaging

Frontiers from Radiomics in Molecular Imaging


Status
Published

1Institute of Molecular Bioimaging and Physiology, Milan, Italy

2San Raffaele Scientific Institute, Milan, Italy


Frontiers from Radiomics in Molecular Imaging

Description

The area of cancer research is nowadays rapidly evolving with basic research deepening on the understanding of molecular mechanisms underlying carcinogenesis and cancer cells spreading. Evidences showed that human cancers frequently display intratumor phenotypic heterogeneity whose nature can have profound implications for both tumor development and therapeutic outcomes. Genotypic and phenotypic profiles have shown increasing diagnostic and prognostic accuracy of ex vivo biopsy studies in several cancer diseases.

Recently, in vivo molecular imaging, such as Computerized Tomography (CT), Magnetic Resonance (MR), functional diffusion-weighted imaging (DWI) MR, and Positron Emission Tomography (PET) are showing intriguing results in characterizing lesions, predicting prognosis and therapy response in many cancer diseases, in particular when quantitative indexes of tumor are used, such as tumor functional volume, apparent diffusion coefficient, standardized uptake value, or other derived indexes. However, limited and contradictory results have been reported and many authors argued that such macroscopic features are not able to properly reflect the intratumor heterogeneity responsible for the different progression or therapy response. Radiomics refers to mathematical methods used to extract a high number of descriptors from in vivo medical images of cancer. The basis hypothesis is that such descriptors are able to capture the heterogeneity of cell underlying the cancer genotype and phenotype.

We invite authors to contribute original research articles as well as review articles that will illustrate and stimulate the increasing effort to understand the heterogeneity of cancer phenotype and to exploit the use of radiomics in targeted molecular imaging studies for the identification of diagnostic/predictive biomarkers of cancer.

Potential topics include but are not limited to the following:

  • Radiomics studies in preclinical and clinical settings
  • Assessment and interpretation of radiomics features
  • Methods for validation of radiomics features
  • Image quantification methods for radiomics

Articles

  • Special Issue
  • - Volume 2019
  • - Article ID 7919545
  • - Editorial

Frontiers from Radiomics in Molecular Imaging

Isabella Castiglioni | Francesca Gallivanone | Claudio Losio
  • Special Issue
  • - Volume 2018
  • - Article ID 3574310
  • - Clinical Study

Radiomic Profiling of Head and Neck Cancer: 18F-FDG PET Texture Analysis as Predictor of Patient Survival

G. Feliciani | F. Fioroni | ... | P. Ciammella
  • Special Issue
  • - Volume 2018
  • - Article ID 5324517
  • - Research Article

Parameters Influencing PET Imaging Features: A Phantom Study with Irregular and Heterogeneous Synthetic Lesions

Francesca Gallivanone | Matteo Interlenghi | ... | Isabella Castiglioni
  • Special Issue
  • - Volume 2018
  • - Article ID 1729071
  • - Research Article

Quantitative Radiomics: Impact of Pulse Sequence Parameter Selection on MRI-Based Textural Features of the Brain

John Ford | Nesrin Dogan | ... | Fei Yang
  • Special Issue
  • - Volume 2018
  • - Article ID 8329041
  • - Clinical Study

Prediction of Chemoresistance in Women Undergoing Neo-Adjuvant Chemotherapy for Locally Advanced Breast Cancer: Volumetric Analysis of First-Order Textural Features Extracted from Multiparametric MRI

M. M. Panzeri | C. Losio | ... | F. De Cobelli
  • Special Issue
  • - Volume 2018
  • - Article ID 5076269
  • - Research Article

DCE-MRI Pharmacokinetic-Based Phenotyping of Invasive Ductal Carcinoma: A Radiomic Study for Prediction of Histological Outcomes

Serena Monti | Marco Aiello | ... | Marco Salvatore
Contrast Media & Molecular Imaging
Publishing Collaboration
More info
Wiley Hindawi logo
 Journal metrics

Metrics will be available once more articles are published.

 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.